MedPath

The Effect of Augmenting Modafinil to Escitalopram on Depressive, Cognitive and Fatigue Symptoms in Patients with Post-Stoke Depressio

Phase 3
Recruiting
Conditions
Post-Stroke Depression.
Mood disorder due to known physiological condition with depressive features
F06.31
Registration Number
IRCT20231106059971N1
Lead Sponsor
niversity of social welfare and rehabilitation sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
66
Inclusion Criteria

Patients'age must be older than 20 years.
ischemic stroke or intracerebral hemorrhage at least 21 days after cerebrovascular accident.
Modified Rankin Scale (MRS) score must be 3 or less.
Consent to participate in the study.
Having a diagnosis of post-stroke depression with a HAM-D score above 8.
The patients must be literate.
MoCA must be above 18.
Constant fatigue reported by the patient with an MFI-20 score equal to 12 or more.

Exclusion Criteria

History of depression, dementia or other psychiatric diseases before stroke
Having other diagnoses with fatigue as a known symptom
Use of Benzodiazepines or Antiepileptic drugs
History of other brain diseases or trauma within 30 days before screening
Pregnancy or intention to become pregnant, breastfeeding

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression score in Hamilton Depression Rating Scale. Timepoint: At the beginning of the study and 2, 4 and 6 weeks after the start of the intervention. Method of measurement: Depression score in Hamilton Depression Rating Scale.;Fatigue score in Fatigue Severity Scale. Timepoint: At the beginning of the study and 2, 4 and 6 weeks after the start of the intervention. Method of measurement: Fatigue Severity Scale.;Cognitive function score in Montreal Cognitive Assessment. Timepoint: At the beginning of the study and 2, 4 and 6 weeks after the start of the intervention. Method of measurement: Montreal Cognitive Assessment.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath